
Lilly to Present New Verzenio Data and Pipeline Updates at ESMO 2025 Annual Meeting
Data includes seven-year results from monarchE trial and updates on multiple investigational cancer therapies. Eli Lilly and Company (NYSE: LLY) announced today that it will present new data from a broad spectrum of its oncology portfolio at the upcoming European…












